Loading Events

« All Events

  • This event has passed.
Dec 8
U.S. – China | 2050: Preventing a Devastating Pandemic
8:00 PM - 9:30 PM

About the Series:
Committee of 100 has launched a thought leadership series in collaboration with leading universities and think tanks across the country that will focus on key topics that the U.S. and China have a joint interest in. The goal of the discussion series is to bypass the heated rhetoric of the moment and bring to bear the complexity and nuances of common challenges facing the U.S. and China, and how each country might tackle these challenges differently in the long term.

About the Webinar:
With China being the first country to be struck by COVID and the U.S. being the country that suffered the most infections and death toll per capita, each country has been dealing with unique pandemic situations. Gathering infectious disease experts from each country to discuss how the next thirty years might look for pandemics and what they have learned from dealing with COVID-19 to help us prepare for and prevent a devastating pandemic, this webinar is jointly organized by Committee of 100 and the China Research Center, and moderated by Zhuo (Adam) Chen, Ph.D., Associate Professor of Health Policy and Management, College of Public Health at the University of Georgia.



Thomas R. Frieden, MD, MPH, President and CEO, Resolve to Save Lives; and former Director, U.S. Centers for Disease Control and Prevention

Dr. Tom Frieden is a physician trained in internal medicine, infectious diseases, public health, and epidemiology. He is former director of the US Centers for Disease Control and Prevention and former commissioner of the New York City Health Department. Dr. Frieden is currently President and CEO of Resolve to Save Lives. Dr. Frieden began his public health career in New York City confronting the largest outbreak of multi-drug resistant tuberculosis to occur in the US. He was then assigned to India, on loan from the Centers for Disease Control and Prevention, where he helped scale up a program for effective tuberculosis diagnosis, treatment, and monitoring. Asked to return to New York City to become Mayor Mike Bloomberg’s Health Commissioner, he directed efforts to reduce smoking and other leading causes of death that increased life expectancy by 3 years. As Director of the US Centers for Disease Control and Prevention, Dr. Frieden oversaw the work that helped end the 2014 West Africa Ebola epidemic. He now leads Resolve to Save Lives that works with countries to prevent 100 million deaths and to make the world safer from epidemics. During the Covid pandemic, Dr. Frieden has overseen an expansion of Resolve to Save Lives activities including policy and program innovations in the United States, counsel to multilateral institutions, and support for rapid response, health care worker safety, and data-driven decision-making in more than 20 countries. Dr. Frieden is also Senior Fellow for Global Health at the Council on Foreign Relations.

George Fu Gao, PhDVice President, National Natural Science Foundation of China; Dean, Savaid Medical School, the University of Chinese Academy of Sciences; and former Director, Chinese Center for Disease Control and Prevention

Gao has been a key leader in the public health field, making remarkable contributions to research and discovery through basic research, clinical evaluation, and advocacy. He has made many remarkable contributions to the scientific field of control and prevention of emerging infectious diseases. Gao has pioneered and made numerous significant original breakthroughs on the pathogenesis mechanisms and pathogen-host interaction of emerging infectious pathogens, including flu, Ebola, MERS, Zika & SARS-CoV-2 viruses, which would greatly facilitate rational design of antiviral drugs and vaccines. His anther great contribution is his work on global health. Gao has given great concern on global health and made substantial efforts in furthering bilateral and multi-lateral health cooperation. Gao pioneers the COVID-19 research and control with virus discovery, vaccine and therapeutic monoclonal antibody development etc. Gao is not only an advocator, but also a practitioner of global health. He obtained his DPhil degree from Oxford University, UK and did his postdoc work in both Oxford University and Harvard University (with a brief stay in Calgary University). Gao worked in Beijing Agricultural University (1986-1991), Oxford University (2001-2006), Institute of Microbiology, Chinese Academy Sciences (2004-2008, Director-General). China CDC (Director-General, 2017-2022), National Science Foundation of China (Vice-President, 2018-). Gao is a member (academician) of Chinese Academy of Sciences (CAS), an international member of the U.S. National Academy of Sciences (NAS), a foreign member of the U.K. Royal Society (RS), a member of the German National Academy of Sciences Leopoldina, a fellow of African Academy of Sciences and a fellow of The World Academy of Sciences (TWAS).

Jeffrey P. Koplan, MD, MPH, Senior Strategic Advisor for CHAMPS; Principal Investigator for IANPHI and the Global Health Institute-China Tobacco Control Partnership; and former Director, U.S. Centers for Disease Control and Prevention

Dr. Jeffrey P. Koplan is Professor of Medicine and Global Health at Emory University and previously was Vice President for Global Health at Emory from 2006 to 2021. He established and served as the Director of the Emory Global Health Institute from 2006-2013. A former Director (1998-2002) and 26-year veteran of the U.S. Centers for Disease Control and Prevention (CDC), Dr. Koplan began his public health career in the early 1970s as a member of the CDC’s Epidemic Intelligence Service. He has played a key role in a variety of domestic and global public health issues, from infectious diseases such as smallpox, SARS, and HIV/AIDS, environmental issues such as the Bhopal chemical disaster, to the health tolls of tobacco, obesity, and chronic diseases. He was the founding Director of CDC’s National Center for Chronic Disease Prevention and Health Promotion. His work has included extensive international assignments in Bangladesh, India, Trinidad and Tobago, as well as US-China bilateral projects, World Bank missions, and World Health Organization consultations. From 1993 to 1998, he was President of the Prudential Center for Health Care Research. Dr. Koplan is a Master of the American College of Physicians, and a member of the National Academy of Medicine (NAM), where he chaired the Committee for Prevention of Childhood Obesity from 2003-2009. He was a trustee of The Robert Wood Johnson Foundation and Yale University.  He is currently a Kaiser Permanente – Georgia Board member and serves on the Board of The China Medical Board. He chaired the Visiting Committee for the Harvard T. H. Chan School of Public Health for 8 years. He is a co-founder and former President of the International Association of National Public Health Institutes (IANPHI). Dr. Koplan is also a senior investigator of the Child Health and Mortality Prevention Surveillance Network (CHAMPS), a major program of the Bill and Melinda Gates Foundation. Dr. Koplan is author of more than 240 scientific papers.

Guoen Liu, PhD, BOYA Distinguished Professor of Economics, Peking University; Dean, PKU Institute for Global Health and Development; and Director, PKU China Center for Health Economic Research (CCHER)

Prof. Liu currently serves as co-organizer for the “US-China Track II Dialogue on Health,” and sits on the China National Expert Panel on COVID-19, and the State Council Health Reform Advisory Commission. He also has served as associate editor for academic journals, including China Economic Quarterly, Health Economics, and the Editor-in-Chief for China Journal of Pharmaceutical Economics. Prior to joining Peking University, he was on full-time faculty at University of Southern California (1994-2000), and University of North Carolina at Chapel Hill (2000-2006). He was the 2004-2005 President of Chinese Economists Society (CES), and the 2004-2006 President of ISPOR Asian Pacific Consortium.

Zhi-Jie Zheng, MD, PhD, Director, China Country Office, Bill & Melinda Gates Foundation

Professor Zhi-Jie (ZJ) Zheng leads the foundation’s efforts to develop and strengthen partnerships across China’s public, private, and nonprofit sectors to advance health and development outcomes in China and around the world. Before joining the foundation in October 2021, Dr. Zheng was at Peking University, serving as K.C. Wong Chair Professor and Head of the Department of Global Health in the School of Public Health and senior vice dean of the university’s Institute for Global Health and Development. He previously served as dean of the School of Public Health at Shanghai Jiao Tong University, as supervisory medical officer and senior program director at the National Heart, Lung, and Blood Institute at the U.S. National Institutes of Health, and as lead epidemiologist and section chief in the Division for Heart Disease and Stroke Prevention at the U.S. Centers for Disease Control and Prevention. Dr. Zheng earned his M.D. from Fudan University in Shanghai, China, along with an M.A. in biomedical ethics. He also holds an M.P.H. in health services research and a Ph.D. in epidemiology from the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill in the United States. He is a Fellow of the American College of Cardiology (FACC) and the American Heart Association (FAHA).


December 8, 2022
8:00 pm - 9:30 pm
Event Categories:
, , ,


Committee of 100
China Research Center